Istanbul Universitesi Dis Hekimligi Fak., Faculty of Dentistry, Department of Oral Surgery, Istanbul University, Prof. Dr. Cavit Orhan Tütengil Sokak.No.4 Vezneciler-Fatih-, 34093, Istanbul, Turkey.
Department of Oral and Maxillofacial Surgery, University of Erlangen-Nuremberg, Glueckstrasse 11, 91054, Erlangen, Germany.
Clin Oral Investig. 2021 May;25(5):3043-3057. doi: 10.1007/s00784-020-03625-6. Epub 2020 Oct 26.
The aim of this study was to investigate if bone regeneration can be promoted by homologous transplantation of STRO-1 sorted (STRO-1+) porcine tooth germ mesenchymal stem cells (TGSCs) with the combination of polyethylenglycol (PEG)-based hydrogel and biphasic calcium phosphate (BCP) scaffolds.
TGSCs were isolated from impacted third molars of domestic pigs. Nine critical-sized defects were created as (1) untreated defect; filled with (2) autogenous bone; (3) BCP + PEG; (4) BCP + PEG + unsorted TGSCs; (5) BCP + unsorted TGSCs; (6) BCP + PEG + STRO-1-sorted TGSCs; (7) BCP + STRO-1-sorted TGSCs; (8) BCP + PEG + osteogenic induced unsorted TGSCs; and (9) BCP + PEG + osteogenic induced STRO-1-sorted TGSCs in 20 domestic pigs. CM-DiI labelling was used to track cells in vivo. Histomorphometric assessment of new bone formation was achieved by toluidine blue O staining and microradiography after 1, 2, 4 and 12 weeks posttransplantation.
Complete healing was achieved in all defects although defects with PEG hydrogel presented better bone formation while STRO-1+ and unsorted TGSCs showed similar ability to form new bone after 12 weeks. Transplanted cells were seen in defects where PEG hydrogel was used as carriers in contrast to defects treated with cells and only bone grafts.
PEG hydrogel is an efficient carrier for homologous stem cell transplantation. TGSCs are capable of promoting bone healing in critical-sized defects in combination with bone graft and PEG hydrogel.
This study provides information about the importance of the delivery vehicle for future translational stem cell delivery approaches.
本研究旨在探讨同源性 STRO-1 分选(STRO-1+)猪牙胚间充质干细胞(TGSCs)与聚乙二醇(PEG)基水凝胶和双相磷酸钙(BCP)支架联合应用是否能促进骨再生。
从家猪阻生第三磨牙中分离 TGSCs。在 20 只家猪中建立 9 个临界尺寸的缺损,分别为:(1)未处理的缺损;(2)用自体骨填充;(3)BCP+PEG;(4)BCP+PEG+未分选 TGSCs;(5)BCP+未分选 TGSCs;(6)BCP+PEG+STRO-1 分选 TGSCs;(7)BCP+STRO-1 分选 TGSCs;(8)BCP+PEG+成骨诱导未分选 TGSCs;(9)BCP+PEG+成骨诱导 STRO-1 分选 TGSCs。CM-DiI 标记用于体内示踪细胞。通过甲苯胺蓝 O 染色和微放射照相术,在移植后 1、2、4 和 12 周评估新骨形成的组织形态计量学评估。
所有缺损均完全愈合,尽管 PEG 水凝胶组的骨形成更好,但 STRO-1+和未分选 TGSCs 在 12 周后具有相似的成骨能力。在用 PEG 水凝胶作为载体的缺损中可见移植细胞,而在用细胞和仅骨移植物治疗的缺损中则未见。
PEG 水凝胶是同源干细胞移植的有效载体。TGSCs 与骨移植物和 PEG 水凝胶联合应用可促进临界尺寸缺损中的骨愈合。
本研究为未来转化干细胞递送方法提供了关于递药载体重要性的信息。